February 1, 2018 / 8:43 AM / in 9 months

BRIEF-Novo Says ‍Semaglutide Reduces Blood Sugar And Weight More Than Dulaglutide​

Feb 1 (Reuters) - NOVO NORDISK:

* SAYS ‍SEMAGLUTIDE DEMONSTRATED SIGNIFICANT REDUCTIONS IN BLOOD SUGAR AND WEIGHT COMPARED WITH DULAGLUTIDE​

* SAYS SUSTAIN 7 TRIAL SHOWED THAT PEOPLE WITH TYPE 2 DIABETES TREATED WITH ONCE-WEEKLY SEMAGLUTIDE EXPERIENCED STATISTICALLY GREATER REDUCTIONS IN HBA1C AND BODY WEIGHT COMPARED TO TREATMENT WITH DULAGLUTIDE​

* SAYS SUSTAIN 7 TRIAL SHOWED ‍FROM A MEAN BASELINE OF 95.2 KG, BODY WEIGHT WAS REDUCED BY 4.6 KG IN PEOPLE TREATED WITH SEMAGLUTIDE 0.5 MG COMPARED WITH 2.3 KG IN PEOPLE TREATED WITH DULAGLUTIDE 0.75 MG​ Further company coverage: (Copenhagen newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below